About this Research Topic
Obesity rates among children and adolescents have almost tripled over the past 25 years, with an increased prevalence of obesity in children and adolescents over the last five decades in all socioeconomic classes. Obesity affects about 17-18% of children. Obesity is defined by an increased body mass index (BMI) ≥ 95 the percentile based on the Centers for Disease Control and Prevention (CDC). Extreme obesity or class 2 is defined as a BMI ≥120% of the 95th percentile or ≥35 kg/m 2; class 3 pediatric obesity is when BMI ≥140% of the 95th percentile or ≥40 kg/m 2, as this is considered to represent an even higher risk group. In- addition to weight stigma for these children, a more serious medical condition, such as type-2 diabetes mellitus, hypertension, metabolic syndrome, heart disease, and polycystic ovarian syndrome have been documented and evaluated routinely. However, less recognized comorbidities are obstructive sleep apnea and obesity hypoventilation syndrome (OHS) which can result in more profound cardiopulmonary complications of obesity in children.
This Research Topic aims to shed light on these seriously growing medical diagnoses in the pediatric population.
This Research Topic aims to shed light on these seriously growing medical diagnoses in the pediatric population.
Keywords: Obesity Hypoventilation syndrome, Obstructive sleep apnea, Sleep-related hypoxemia, Bi-level therapy, CPAP therapy, NIV therapy, PAP therapy, Obesity, Sleep related breathing disorders.
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
